MedPath
HSA Approval

CAFFOX TABLET

SIN11746P

CAFFOX TABLET

CAFFOX TABLET

December 26, 2001

JOYSON PTE. LTD.

JOYSON PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOYSON PTE. LTD.
Licence HolderJOYSON PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N02CA52

ergotamine, combinations excl. psycholeptics

Manufacturer Information

JOYSON PTE. LTD.

T O PHARMA CO LTD

Active Ingredients

CAFFEINE

100 mg

Caffeine

ERGOTAMINE TARTRATE

1 mg

Ergotamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CAFFOX TABLET - HSA Approval | MedPath